Sort
15,842 grants matching “pancreatic cancer”
Pancreatic Cancer Treatment Using Surgery &Gene Therapy
$267,890Baylor College Of Medicine · R01 · FY2004 · CA
Pancreatic Cancer Treatment Using Surgery &Gene Therapy
$267,890Baylor College Of Medicine · R01 · FY2003 · CA
Pancreatic Cancer Treatment Using Surgery &Gene Therapy
$267,890Baylor College Of Medicine · R01 · FY2005 · CA
Cytosolic Phospholipase in Transformed Cells
$267,846Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2006 · CA
Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network
$267,802Evan L Fogel · Indiana University Indianapolis · U01 · FY2018 · DK
METABOLIC ENGINEERING OF REACTIVE GLYCOCONJUGATES
$267,697University Of California Berkeley · R01 · FY2003 · GM
Molecular Imaging of Fibrosis for Improved Treatment Planning of Pancreatic Ductal Adenocarcinoma
$267,629Shadi Abdar Esfahani · Massachusetts General Hospital · K08 · FY2024 · CA
Molecular Imaging of Fibrosis for Improved Treatment Planning of Pancreatic Ductal Adenocarcinoma
$267,629Shadi Abdar Esfahani · Massachusetts General Hospital · K08 · FY2025 · CA
Molecular Imaging of Fibrosis for Improved Treatment Planning of Pancreatic Ductal Adenocarcinoma
$267,629Shadi Abdar Esfahani · Massachusetts General Hospital · K08 · FY2023 · CA
Molecular Imaging of Fibrosis for Improved Treatment Planning of Pancreatic Ductal Adenocarcinoma
$267,629Shadi Abdar Esfahani · Massachusetts General Hospital · K08 · FY2022 · CA
Preclinical platform for theranostic nanoparticles in pancreatic cancer
$267,620Nancy J Halas · Rice University · U01 · FY2013 · CA
Core B: Liver Metastasis Resource Core (LMRC)
$267,550Edwin Melencio Posadas · Cedars-Sinai Medical Center · P01 · FY2020 · CA
Imaging and theranostics to detect and promote an immune reactive tumor microenvironment
$267,481Zaver M Bhujwalla · Ut Southwestern Medical Center · P41 · FY2024 · EB
NFAT Transcription Factors as Therapeutic Targets in Pancreatic Cancer
$267,478Daniel D Billadeau · Mayo Clinic Rochester · P50 · FY2017 · CA
Biostatistics Core
$267,472Ann Laura Oberg · Mayo Clinic Rochester · P50 · FY2017 · CA
Cytoskeletal Dynamics in Pancreatic Cancer Metastasis
$267,361Mark A. Mc Niven · Mayo Clinic Rochester · R01 · FY2014 · CA
EPIDERMAL GROWTH FACTOR RECEPTORS AND PANCREATIC CANCER
$267,318University Of California Irvine · R01 · FY2001 · CA
NQO1 Inhibitors and Pancreatic Cancer Therapy
$267,302David Ross · University Of Colorado Denver · R01 · FY2006 · CA
Single-molecule mechanical detection of protein and microRNA cancer biomarkers
$267,258Wesley Philip Wong · Boston Children'S Hospital · R21 · FY2017 · CA
Evaluation of In Vitro Companion Diagnostic Monoclonal Antibodies for Use in a St
$267,215Christopher Horvath · Intica Biomedical, Inc. · R41 · FY2012 · CA
Developmental Funds
$267,112Louis M Weiner · Georgetown University · P30 · FY2020 · CA
Developmental Funds
$267,112Louis M Weiner · Georgetown University · P30 · FY2019 · CA
Developmental Funds
$267,112Sharon J Levy · Georgetown University · P30 · FY2022 · CA
Developmental Funds
$267,112Louis M Weiner · Georgetown University · P30 · FY2021 · CA
Phase 1 Trial of Anti-Mesothelin Chimeric Immunoreceptor
$267,026Christina S Chu · University Of Pennsylvania · R21 · FY2007 · CA